Cargando…

COVID-19 Coagulopathy: From Pathogenesis to Treatment

Coronavirus disease 2019 (COVID-19) has emerged as a pandemic at the end of 2019 and continues to exert an unfavorable worldwide health impact on a large proportion of the population. A remarkable feature of COVID-19 is the precipitation of a hypercoagulable state, mainly in severe cases, leading to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alnima, Teba, Mulder, Mark M.G., van Bussel, Bas C.T., ten Cate, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059042/ https://www.ncbi.nlm.nih.gov/pubmed/35499460 http://dx.doi.org/10.1159/000522498

Ejemplares similares

Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
por: Nagy, Magdolna, et al.
Publicado: (2022)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022)

A known unknown? Pharmacological prevention of venous thromboembolism in nursing home residents
por: Brüggemann, Renée A. G., et al.
Publicado: (2021)

Applications of rotational thromboelastometry in heparin monitoring in critical COVID-19 disease: Observations in the Maastricht Intensive Care COVID cohort
por: Schultinge, Lejan, et al.
Publicado: (2023)

Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New Developments
por: Alnima, Teba, et al.
Publicado: (2012)

The prevalence of pulmonary embolism in patients with COVID-19 and respiratory decline: A three-setting comparison
por: Brüggemann, Renée A.G., et al.
Publicado: (2020)

Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO
por: Streng, Alexander S., et al.
Publicado: (2020)

High flow nasal cannula in older vulnerable COVID-19 patients: A missed opportunity?
por: Willems, Ruth A.L., et al.
Publicado: (2021)

Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy
por: Serrano, Manuel, et al.
Publicado: (2022)

Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
por: van de Berg, Tom W., et al.
Publicado: (2021)

COVID-19 and Coagulopathy
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

Coagulopathy and COVID-19
por: Lorini, Ferdinando Luca, et al.
Publicado: (2021)

Coagulopathy in COVID-19
por: Lio, Ka U, et al.
Publicado: (2021)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease
por: Alnima, T., et al.
Publicado: (2023)

Thrombosis and Coagulopathy in COVID-19
por: Gómez-Mesa, Juan Esteban, et al.
Publicado: (2021)

Reply to: COVID-19 and Coagulopathy
por: Rodríguez, Cristina, et al.
Publicado: (2021)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy
por: Li, Jing, et al.
Publicado: (2021)

Lessons learnt from COVID‐19 coagulopathy
por: Thachil, Jecko
Publicado: (2021)

Viral Coagulopathy in Patients With COVID-19: Treatment and Care
por: Kipshidze, Nickolas, et al.
Publicado: (2020)

Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy
por: Umemura, Yutaka, et al.
Publicado: (2020)

Understanding COVID-19-associated coagulopathy
por: Conway, Edward M., et al.
Publicado: (2022)

COVID-19 associated coagulopathy and thrombosis in cancer
por: Levi, Marcel, et al.
Publicado: (2022)

Thrombosis management in times of COVID-19 epidemy; a Dutch perspective
por: ten Cate, Hugo
Publicado: (2020)

Curcumin and Coagulopathy in the COVID19 Era
por: Suresh, Padmanaban S.
Publicado: (2020)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

The unique characteristics of COVID-19 coagulopathy
por: Iba, Toshiaki, et al.
Publicado: (2020)

The coagulopathy, endotheliopathy, and vasculitis of COVID-19
por: Iba, Toshiaki, et al.
Publicado: (2020)

COVID-19 Related Arterial Coagulopathy
por: Singh, Gagandeep, et al.
Publicado: (2020)

COVID-19 coagulopathy: an evolving story
por: The Lancet Haematology
Publicado: (2020)

COVID-19 : coagulopathie et thrombose
por: Tazi Mezalek, Z.
Publicado: (2021)

COVID-19 coagulopathy and antiphospholipid syndrome
por: Serrano, Manuel, et al.
Publicado: (2022)

COVID‐19 and acute coagulopathy in pregnancy
por: Vlachodimitropoulou Koumoutsea, Evangelia, et al.
Publicado: (2020)

Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
por: Agbuduwe, Charles, et al.
Publicado: (2020)

COVID-19 associated coagulopathy: Mechanisms and host-directed treatment
por: Plášek, Jiří, et al.
Publicado: (2022)

Nuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment
por: Lindsay, Patrick J, et al.
Publicado: (2021)

Comparison of the coagulopathies associated with COVID‐19 and sepsis
por: Campbell, Robert A., et al.
Publicado: (2021)

THE UNKNOWN: POST COVID-19 COAGULOPATHY WITH WARFARIN FAILURE
por: DOUEN, AARON, et al.
Publicado: (2021)

COVID-19 update: Covid-19-associated coagulopathy
por: Becker, Richard C.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n80a3mnbapmhmpn2at51t2lf44